Hamlet Pharma builds for a promising future
Hamlet Pharma is proud to announce that the contract with the European union has been signed, granting pre-payment of the 23 million SEK EU Accelerator grant that was awarded to the company this spring. With this funding secured, Hamlet Pharma can now introduce a new corporate structure, strengthening our expertise and leadership in finance, business development and specific business areas.The company has put in place an Executive committee, with Anders Wihlborn as financial advisor, the CEO Mats Persson, the chairman of the board Catharina Svanborg and Jan Zetterberg, whose extensive